For more on oral versus injectable administration, see our next article, the BPC-157 Administration Guide
The premise of that study was to identify biomarkers of pulmonary neuroendocrine tumors
Clinicians working with patients who have compromised gut barrier function, often framed as increased intestinal permeability or "leaky gut," sometimes extend oral BPC-157 protocols to ten to twelve weeks given the chronicity of the underlying pathology
Glutathione (GSH) as distributed by Peptides Lab UK is not intended for, and must not be used for, human consumption, medical treatment, self-administration, veterinary applications, or any use outside of a controlled laboratory environment
Blood work to track BPC-157 BPC-157 doesn't have a single direct biomarker, so tracking focuses on the inflammation it's meant to reduce and on safety: hs-CRP a sensitive inflammation marker
& Hui, D